Posted February 7, 2026 at 12:26 pm by globanspharma

NSCLC treatment with Sotoxen 120mg Capsule

A targeted oral cancer therapy which inhibits a specific mutated protein that drives tumor growth in certain lung cancers. Sotoxen 120mg Capsule uses for NSCLC with KRAS G12C mutation include slowing progression of locally advanced or metastatic non‑small cell lung cancer in adults who have had prior treatment. You can visit Globans Pharma to know more about such medicines.

Details

Email
globansp@gmail.com

On map


post free classified ads - free advertising
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.